◆ NeutralIRON
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire Inc.·
The Rosen Law Firm is investigating potential securities claims against Disc Medicine, Inc. (NASDAQ: IRON) for allegedly issuing materially misleading business information. The investigation was triggered by an FDA Complete Response Letter on February 13, 2026, regarding the company's bitopertin program, which caused the stock to fall 22%. Investors who suffered losses are encouraged to join a prospective class action lawsuit.
Read Full Article at GlobeNewswire Inc. →